1α,25-dihydroxyvitamin D(3) mitigates cancer cell mediated mitochondrial dysfunction in human skeletal muscle cells

Cancer cachexia is associated with muscle weakness and atrophy. We investigated whether 1α,25-dihydroxyvitamin D(3) (1α,25(OH)(2)D(3)), which has previously been shown to increase skeletal myoblast oxygen consumption rate, could reverse the deleterious effects of tumor cell conditioned medium on myo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Zachary C., Craig, Theodore A., Wang, Xuewei, Delmotte, Philippe, Salisbury, Jeffrey L., Lanza, Ian R., Sieck, Gary C., Kumar, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812288/
https://www.ncbi.nlm.nih.gov/pubmed/29366785
http://dx.doi.org/10.1016/j.bbrc.2018.01.092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812288/
https://www.ncbi.nlm.nih.gov/pubmed/29366785
http://dx.doi.org/10.1016/j.bbrc.2018.01.092

Ejemplares similares